Ekf Diagnostics Share Price (EKF)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 31.50on 17-01-2020 at 16:30:00
Change -0.20 -0.61%
Buy 33.70
Sell 31.50
Buy / Sell EKF Shares
Sponsored Financial Content
Last Trade: Buy 110,000 at 32.784p
Day's Volume: 118,828
Last Close: 32.80p
Open: 32.00p
ISIN: GB0031509804
Day's Range 31.50p - 32.00p
52wk Range: 29.00p - 37.70p
Market Capitalisation: £143m
VWAP: 0.00p
Shares in Issue: 454m

Recent Trades History Ekf Diagnostics (EKF)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy*110,00032.784Ordinary
Delayed publication
16:10:23 - 17-Jan-20
Buy*7,50032.823Ordinary
13:39:56 - 17-Jan-20
Buy*30,00032.823Ordinary
13:17:33 - 17-Jan-20
Sell*1,00032.277Ordinary
12:52:35 - 17-Jan-20
Buy*25,00032.823Ordinary
12:05:04 - 17-Jan-20
Sell*64231.50Automatic Execution
11:51:54 - 17-Jan-20
Sell*1,00031.537Ordinary
11:10:34 - 17-Jan-20
Sell*1,35831.60Automatic Execution
10:59:52 - 17-Jan-20
Sell*10,00032.00Automatic Execution
10:34:49 - 17-Jan-20
Sell*15,00032.00Ordinary
10:34:43 - 17-Jan-20

Share Price History for Ekf Diagnostics

Time period:
to
Date Open High Low Close
16th Jan 2020 (Thu)32.450.000.0032.80
15th Jan 2020 (Wed)32.5033.4032.5032.45
14th Jan 2020 (Tue)33.250.000.0033.25
13th Jan 2020 (Mon)33.9033.9033.9033.25
10th Jan 2020 (Fri)33.250.000.0033.50
9th Jan 2020 (Thu)33.400.000.0033.25
8th Jan 2020 (Wed)32.750.000.0033.40
7th Jan 2020 (Tue)33.750.000.0032.75
6th Jan 2020 (Mon)32.1032.1032.1033.75
3rd Jan 2020 (Fri)33.2033.2032.5032.90
2nd Jan 2020 (Thu)33.6033.6033.6033.60
1st Jan 2020 (Wed)34.250.000.0034.25
31st Dec 2019 (Tue)34.250.000.0034.25
30th Dec 2019 (Mon)34.500.000.0034.25
27th Dec 2019 (Fri)34.550.000.0034.50
26th Dec 2019 (Thu)00.000.0034.55
25th Dec 2019 (Wed)34.500.000.0034.55
24th Dec 2019 (Tue)34.500.000.0034.55
23rd Dec 2019 (Mon)34.250.000.0034.50
20th Dec 2019 (Fri)35.2035.5033.6034.25
19th Dec 2019 (Thu)34.0034.3034.0034.40

News about Ekf Diagnostics (EKF)

AstraZenecca Signs Partnership Deals with Roche and Qiagen

News - Tuesday, July 29, 2014

AstraZeneca PLC has signed deals to partner with Roche and Qiagen, with plans to develop two separate diagnostic tests which could help to identify patients that may benefit from the company's lung cancer medication....

FTSE 100 Latest
Value7,674.56
Change64.75


Login to your account

Forgot Password?

Not Registered